Skip to main content
. 2018 May 23;109(6):1920–1929. doi: 10.1111/cas.13600

Figure 4.

Figure 4

Changes in testosterone (A), luteinizing hormone (LH) (B), follicle stimulating hormone (FSH) (C), and prostate‐specific antigen (PSA) in the full analysis set of Japanese prostate cancer patients treated with degarelix (n = 117) or goserelin (n = 117)